Blood Test Identifies More Treatable Cancer Mutations Than Tissue Biopsy Alone

Penn study shows patients with treatable mutations identified by liquid biopsy also largely respond to therapy October 11 2018 PHILADELPHIA In one of the largest clinical studies to ever examine the impact of using a blood test to detect treatable mutati [...]

More women with early-stage breast cancer may be able to avoid chemotherapy

Results from a large clinical trial called TAILORx showed that more women with early-stage breast cancer may now be able to avoid chemotherapy after surgery The women who participated in the study had hormone receptor-positive HER2-negative axillary node- [...]

Designation for Advanced Cutaneous Squamous Cell Carcinoma

Breakthrough Designation for Advanced Cutaneous Squamous Cell Carcinoma The US Food and Drug Administration FDA has approved cemiplimab REGN2810 for the treatment of adults with metastatic cutaneous squamous cell carcinoma CSCC and adults with locally adv [...]

duvelisib (COPIKTRA, Verastem, Inc.) for adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)

The Food and Drug Administration granted regular approval to duvelisib COPIKTRA Verastem Inc for adult patients with relapsed or refractory chronic lymphocytic leukemia CLL or small lymphocytic lymphoma SLL after at least two prior therapies In addition d [...]

Clinical Trial Shows Best Outcomes to Date for Older Hodgkin Lymphoma Patients

Recently published results of a phase 2 clinical trial have shown the best outcomes to date for newly diagnosed older Hodgkin lymphoma patients treated with brentuximab vedotin given before and after doxorubicin vinblastine and dacarbazine AVD chemotherap [...]

First In Class Immunostimulating Anticancer Agent able to Directly Inhibit Tumor Signaling and Kill Tumor Cells, is in Clinical Trial for Glioblastoma and Melanoma Metastatic to the Brain

Small molecule lead drug candidate blocks a critical target for tumors and crosses the blood brain barrier begins first brain cancer patient dosing in clinical trial at MD Anderson Cancer Center HOUSTON TX September 13 2018 In the ongoing challenge to c [...]

Targeted Combination Treatment for Melanoma now Available

The US Food and Drug Administration FDA approved the combination of Bratovi encorafenib and Mektovi binimetinibfor use in patients with unresectable or metastatic melanoma with aBRAFV600E or V600K mutation as detected by an FDA-approved test About Braftov [...]

AbbVie Announces IMBRUVICA® (ibrutinib) Plus Rituximab Approval by U.S. FDA as First Chemotherapy-Free Combination Treatment in Adults with Waldenström’s Macroglobulinemia, a Rare Type of Blood Cancer

PRESS RELEASE PR Newswire Aug 27 2018 0700 AM NORTH CHICAGO Ill Aug 27 2018 PRNewswire 8212 AbbVie NYSE ABBV a research-based global biopharmaceutical company todayannounced that the US Food and Drug Administration FDA approved IMBRUVICA ibrutinib plus ri [...]

Immune-mediated Nephritis Reported to Occur with Tecentriq®

Immune-mediated Nephritis Reported to Occur with Tecentriq Enough patients have developed immune-mediated nephritis which has been biopsy-confirmed in many cases that the manufacturer of Tecentriq now considers this to be an important adverse reaction The [...]

About The National Ovarian Cancer Coalition

Where do you go when youre first delivered the news You have cancer For many women diagnosed with ovarian cancer the answer is the National Ovarian Cancer Coalition NOCC With more than 80 chapters nationwide a Web site wwwovarianorg that includes active m [...]